COVID-19 Impact on Global Human Microbiome Modulators Market Size, Status and Forecast 2020-2026
The human microbiota is an aggregate of microorganisms residing in the human body, mostly in the gastrointestinal tract.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Human Microbiome Modulators market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Human Microbiome Modulators industry.
Based on our recent survey, we have several different scenarios about the Human Microbiome Modulators YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Human Microbiome Modulators will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Human Microbiome Modulators market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Human Microbiome Modulators market in terms of revenue.
Players, stakeholders, and other participants in the global Human Microbiome Modulators market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Human Microbiome Modulators market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Human Microbiome Modulators market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Human Microbiome Modulators market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Human Microbiome Modulators market.
The following players are covered in this report:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Human Microbiome Modulators market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Human Microbiome Modulators industry.
Based on our recent survey, we have several different scenarios about the Human Microbiome Modulators YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Human Microbiome Modulators will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Human Microbiome Modulators market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Human Microbiome Modulators market in terms of revenue.
Players, stakeholders, and other participants in the global Human Microbiome Modulators market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Human Microbiome Modulators market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Human Microbiome Modulators market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Human Microbiome Modulators market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Human Microbiome Modulators market.
The following players are covered in this report:
- Bayer
- BioGaia
- Chr. Hansen Holding
- DowDuPont
- Ingredion
- ISOThrive
- Jarrow Formulas
- DSM
- Lallemand
- Sanofi
- Probiotics and Creams
- Prebiotics and Dietary Supplements
- Drugs
- Digestive Health
- Immune Health
- Oral Health
- Others
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Human Microbiome Modulators Revenue
1.4 Market Analysis by Type
1.4.1 Global Human Microbiome Modulators Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Probiotics and Creams
1.4.3 Prebiotics and Dietary Supplements
1.4.4 Drugs
1.5 Market by Application
1.5.1 Global Human Microbiome Modulators Market Share by Application: 2020 VS 2026
1.5.2 Digestive Health
1.5.3 Immune Health
1.5.4 Oral Health
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Human Microbiome Modulators Industry Impact
1.6.1 How the Covid-19 is Affecting the Human Microbiome Modulators Industry
1.6.1.1 Human Microbiome Modulators Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Human Microbiome Modulators Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Human Microbiome Modulators Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Human Microbiome Modulators Market Perspective (2015-2026)
2.2 Human Microbiome Modulators Growth Trends by Regions
2.2.1 Human Microbiome Modulators Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Human Microbiome Modulators Historic Market Share by Regions (2015-2020)
2.2.3 Human Microbiome Modulators Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Human Microbiome Modulators Market Growth Strategy
2.3.6 Primary Interviews with Key Human Microbiome Modulators Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Human Microbiome Modulators Players by Market Size
3.1.1 Global Top Human Microbiome Modulators Players by Revenue (2015-2020)
3.1.2 Global Human Microbiome Modulators Revenue Market Share by Players (2015-2020)
3.1.3 Global Human Microbiome Modulators Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Human Microbiome Modulators Market Concentration Ratio
3.2.1 Global Human Microbiome Modulators Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Human Microbiome Modulators Revenue in 2019
3.3 Human Microbiome Modulators Key Players Head office and Area Served
3.4 Key Players Human Microbiome Modulators Product Solution and Service
3.5 Date of Enter into Human Microbiome Modulators Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Human Microbiome Modulators Historic Market Size by Type (2015-2020)
4.2 Global Human Microbiome Modulators Forecasted Market Size by Type (2021-2026)
5 HUMAN MICROBIOME MODULATORS BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Human Microbiome Modulators Market Size by Application (2015-2020)
5.2 Global Human Microbiome Modulators Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Human Microbiome Modulators Market Size (2015-2020)
6.2 Human Microbiome Modulators Key Players in North America (2019-2020)
6.3 North America Human Microbiome Modulators Market Size by Type (2015-2020)
6.4 North America Human Microbiome Modulators Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Human Microbiome Modulators Market Size (2015-2020)
7.2 Human Microbiome Modulators Key Players in Europe (2019-2020)
7.3 Europe Human Microbiome Modulators Market Size by Type (2015-2020)
7.4 Europe Human Microbiome Modulators Market Size by Application (2015-2020)
8 CHINA
8.1 China Human Microbiome Modulators Market Size (2015-2020)
8.2 Human Microbiome Modulators Key Players in China (2019-2020)
8.3 China Human Microbiome Modulators Market Size by Type (2015-2020)
8.4 China Human Microbiome Modulators Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Human Microbiome Modulators Market Size (2015-2020)
9.2 Human Microbiome Modulators Key Players in Japan (2019-2020)
9.3 Japan Human Microbiome Modulators Market Size by Type (2015-2020)
9.4 Japan Human Microbiome Modulators Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Human Microbiome Modulators Market Size (2015-2020)
10.2 Human Microbiome Modulators Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Human Microbiome Modulators Market Size by Type (2015-2020)
10.4 Southeast Asia Human Microbiome Modulators Market Size by Application (2015-2020)
11 INDIA
11.1 India Human Microbiome Modulators Market Size (2015-2020)
11.2 Human Microbiome Modulators Key Players in India (2019-2020)
11.3 India Human Microbiome Modulators Market Size by Type (2015-2020)
11.4 India Human Microbiome Modulators Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Human Microbiome Modulators Market Size (2015-2020)
12.2 Human Microbiome Modulators Key Players in Central & South America (2019-2020)
12.3 Central & South America Human Microbiome Modulators Market Size by Type (2015-2020)
12.4 Central & South America Human Microbiome Modulators Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Bayer
13.1.1 Bayer Company Details
13.1.2 Bayer Business Overview and Its Total Revenue
13.1.3 Bayer Human Microbiome Modulators Introduction
13.1.4 Bayer Revenue in Human Microbiome Modulators Business (2015-2020))
13.1.5 Bayer Recent Development
13.2 BioGaia
13.2.1 BioGaia Company Details
13.2.2 BioGaia Business Overview and Its Total Revenue
13.2.3 BioGaia Human Microbiome Modulators Introduction
13.2.4 BioGaia Revenue in Human Microbiome Modulators Business (2015-2020)
13.2.5 BioGaia Recent Development
13.3 Chr. Hansen Holding
13.3.1 Chr. Hansen Holding Company Details
13.3.2 Chr. Hansen Holding Business Overview and Its Total Revenue
13.3.3 Chr. Hansen Holding Human Microbiome Modulators Introduction
13.3.4 Chr. Hansen Holding Revenue in Human Microbiome Modulators Business (2015-2020)
13.3.5 Chr. Hansen Holding Recent Development
13.4 DowDuPont
13.4.1 DowDuPont Company Details
13.4.2 DowDuPont Business Overview and Its Total Revenue
13.4.3 DowDuPont Human Microbiome Modulators Introduction
13.4.4 DowDuPont Revenue in Human Microbiome Modulators Business (2015-2020)
13.4.5 DowDuPont Recent Development
13.5 Ingredion
13.5.1 Ingredion Company Details
13.5.2 Ingredion Business Overview and Its Total Revenue
13.5.3 Ingredion Human Microbiome Modulators Introduction
13.5.4 Ingredion Revenue in Human Microbiome Modulators Business (2015-2020)
13.5.5 Ingredion Recent Development
13.6 ISOThrive
13.6.1 ISOThrive Company Details
13.6.2 ISOThrive Business Overview and Its Total Revenue
13.6.3 ISOThrive Human Microbiome Modulators Introduction
13.6.4 ISOThrive Revenue in Human Microbiome Modulators Business (2015-2020)
13.6.5 ISOThrive Recent Development
13.7 Jarrow Formulas
13.7.1 Jarrow Formulas Company Details
13.7.2 Jarrow Formulas Business Overview and Its Total Revenue
13.7.3 Jarrow Formulas Human Microbiome Modulators Introduction
13.7.4 Jarrow Formulas Revenue in Human Microbiome Modulators Business (2015-2020)
13.7.5 Jarrow Formulas Recent Development
13.8 DSM
13.8.1 DSM Company Details
13.8.2 DSM Business Overview and Its Total Revenue
13.8.3 DSM Human Microbiome Modulators Introduction
13.8.4 DSM Revenue in Human Microbiome Modulators Business (2015-2020)
13.8.5 DSM Recent Development
13.9 Lallemand
13.9.1 Lallemand Company Details
13.9.2 Lallemand Business Overview and Its Total Revenue
13.9.3 Lallemand Human Microbiome Modulators Introduction
13.9.4 Lallemand Revenue in Human Microbiome Modulators Business (2015-2020)
13.9.5 Lallemand Recent Development
13.10 Sanofi
13.10.1 Sanofi Company Details
13.10.2 Sanofi Business Overview and Its Total Revenue
13.10.3 Sanofi Human Microbiome Modulators Introduction
13.10.4 Sanofi Revenue in Human Microbiome Modulators Business (2015-2020)
13.10.5 Sanofi Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Human Microbiome Modulators Revenue
1.4 Market Analysis by Type
1.4.1 Global Human Microbiome Modulators Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Probiotics and Creams
1.4.3 Prebiotics and Dietary Supplements
1.4.4 Drugs
1.5 Market by Application
1.5.1 Global Human Microbiome Modulators Market Share by Application: 2020 VS 2026
1.5.2 Digestive Health
1.5.3 Immune Health
1.5.4 Oral Health
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Human Microbiome Modulators Industry Impact
1.6.1 How the Covid-19 is Affecting the Human Microbiome Modulators Industry
1.6.1.1 Human Microbiome Modulators Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Human Microbiome Modulators Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Human Microbiome Modulators Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Human Microbiome Modulators Market Perspective (2015-2026)
2.2 Human Microbiome Modulators Growth Trends by Regions
2.2.1 Human Microbiome Modulators Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Human Microbiome Modulators Historic Market Share by Regions (2015-2020)
2.2.3 Human Microbiome Modulators Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Human Microbiome Modulators Market Growth Strategy
2.3.6 Primary Interviews with Key Human Microbiome Modulators Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Human Microbiome Modulators Players by Market Size
3.1.1 Global Top Human Microbiome Modulators Players by Revenue (2015-2020)
3.1.2 Global Human Microbiome Modulators Revenue Market Share by Players (2015-2020)
3.1.3 Global Human Microbiome Modulators Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Human Microbiome Modulators Market Concentration Ratio
3.2.1 Global Human Microbiome Modulators Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Human Microbiome Modulators Revenue in 2019
3.3 Human Microbiome Modulators Key Players Head office and Area Served
3.4 Key Players Human Microbiome Modulators Product Solution and Service
3.5 Date of Enter into Human Microbiome Modulators Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Human Microbiome Modulators Historic Market Size by Type (2015-2020)
4.2 Global Human Microbiome Modulators Forecasted Market Size by Type (2021-2026)
5 HUMAN MICROBIOME MODULATORS BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Human Microbiome Modulators Market Size by Application (2015-2020)
5.2 Global Human Microbiome Modulators Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Human Microbiome Modulators Market Size (2015-2020)
6.2 Human Microbiome Modulators Key Players in North America (2019-2020)
6.3 North America Human Microbiome Modulators Market Size by Type (2015-2020)
6.4 North America Human Microbiome Modulators Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Human Microbiome Modulators Market Size (2015-2020)
7.2 Human Microbiome Modulators Key Players in Europe (2019-2020)
7.3 Europe Human Microbiome Modulators Market Size by Type (2015-2020)
7.4 Europe Human Microbiome Modulators Market Size by Application (2015-2020)
8 CHINA
8.1 China Human Microbiome Modulators Market Size (2015-2020)
8.2 Human Microbiome Modulators Key Players in China (2019-2020)
8.3 China Human Microbiome Modulators Market Size by Type (2015-2020)
8.4 China Human Microbiome Modulators Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Human Microbiome Modulators Market Size (2015-2020)
9.2 Human Microbiome Modulators Key Players in Japan (2019-2020)
9.3 Japan Human Microbiome Modulators Market Size by Type (2015-2020)
9.4 Japan Human Microbiome Modulators Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Human Microbiome Modulators Market Size (2015-2020)
10.2 Human Microbiome Modulators Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Human Microbiome Modulators Market Size by Type (2015-2020)
10.4 Southeast Asia Human Microbiome Modulators Market Size by Application (2015-2020)
11 INDIA
11.1 India Human Microbiome Modulators Market Size (2015-2020)
11.2 Human Microbiome Modulators Key Players in India (2019-2020)
11.3 India Human Microbiome Modulators Market Size by Type (2015-2020)
11.4 India Human Microbiome Modulators Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Human Microbiome Modulators Market Size (2015-2020)
12.2 Human Microbiome Modulators Key Players in Central & South America (2019-2020)
12.3 Central & South America Human Microbiome Modulators Market Size by Type (2015-2020)
12.4 Central & South America Human Microbiome Modulators Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Bayer
13.1.1 Bayer Company Details
13.1.2 Bayer Business Overview and Its Total Revenue
13.1.3 Bayer Human Microbiome Modulators Introduction
13.1.4 Bayer Revenue in Human Microbiome Modulators Business (2015-2020))
13.1.5 Bayer Recent Development
13.2 BioGaia
13.2.1 BioGaia Company Details
13.2.2 BioGaia Business Overview and Its Total Revenue
13.2.3 BioGaia Human Microbiome Modulators Introduction
13.2.4 BioGaia Revenue in Human Microbiome Modulators Business (2015-2020)
13.2.5 BioGaia Recent Development
13.3 Chr. Hansen Holding
13.3.1 Chr. Hansen Holding Company Details
13.3.2 Chr. Hansen Holding Business Overview and Its Total Revenue
13.3.3 Chr. Hansen Holding Human Microbiome Modulators Introduction
13.3.4 Chr. Hansen Holding Revenue in Human Microbiome Modulators Business (2015-2020)
13.3.5 Chr. Hansen Holding Recent Development
13.4 DowDuPont
13.4.1 DowDuPont Company Details
13.4.2 DowDuPont Business Overview and Its Total Revenue
13.4.3 DowDuPont Human Microbiome Modulators Introduction
13.4.4 DowDuPont Revenue in Human Microbiome Modulators Business (2015-2020)
13.4.5 DowDuPont Recent Development
13.5 Ingredion
13.5.1 Ingredion Company Details
13.5.2 Ingredion Business Overview and Its Total Revenue
13.5.3 Ingredion Human Microbiome Modulators Introduction
13.5.4 Ingredion Revenue in Human Microbiome Modulators Business (2015-2020)
13.5.5 Ingredion Recent Development
13.6 ISOThrive
13.6.1 ISOThrive Company Details
13.6.2 ISOThrive Business Overview and Its Total Revenue
13.6.3 ISOThrive Human Microbiome Modulators Introduction
13.6.4 ISOThrive Revenue in Human Microbiome Modulators Business (2015-2020)
13.6.5 ISOThrive Recent Development
13.7 Jarrow Formulas
13.7.1 Jarrow Formulas Company Details
13.7.2 Jarrow Formulas Business Overview and Its Total Revenue
13.7.3 Jarrow Formulas Human Microbiome Modulators Introduction
13.7.4 Jarrow Formulas Revenue in Human Microbiome Modulators Business (2015-2020)
13.7.5 Jarrow Formulas Recent Development
13.8 DSM
13.8.1 DSM Company Details
13.8.2 DSM Business Overview and Its Total Revenue
13.8.3 DSM Human Microbiome Modulators Introduction
13.8.4 DSM Revenue in Human Microbiome Modulators Business (2015-2020)
13.8.5 DSM Recent Development
13.9 Lallemand
13.9.1 Lallemand Company Details
13.9.2 Lallemand Business Overview and Its Total Revenue
13.9.3 Lallemand Human Microbiome Modulators Introduction
13.9.4 Lallemand Revenue in Human Microbiome Modulators Business (2015-2020)
13.9.5 Lallemand Recent Development
13.10 Sanofi
13.10.1 Sanofi Company Details
13.10.2 Sanofi Business Overview and Its Total Revenue
13.10.3 Sanofi Human Microbiome Modulators Introduction
13.10.4 Sanofi Revenue in Human Microbiome Modulators Business (2015-2020)
13.10.5 Sanofi Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Human Microbiome Modulators Key Market Segments
Table 2. Key Players Covered: Ranking by Human Microbiome Modulators Revenue
Table 3. Ranking of Global Top Human Microbiome Modulators Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Human Microbiome Modulators Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Probiotics and Creams
Table 6. Key Players of Prebiotics and Dietary Supplements
Table 7. Key Players of Drugs
Table 8. COVID-19 Impact Global Market: (Four Human Microbiome Modulators Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Human Microbiome Modulators Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Human Microbiome Modulators Players to Combat Covid-19 Impact
Table 13. Global Human Microbiome Modulators Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Human Microbiome Modulators Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Human Microbiome Modulators Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Human Microbiome Modulators Market Share by Regions (2015-2020)
Table 17. Global Human Microbiome Modulators Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Human Microbiome Modulators Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Human Microbiome Modulators Market Growth Strategy
Table 23. Main Points Interviewed from Key Human Microbiome Modulators Players
Table 24. Global Human Microbiome Modulators Revenue by Players (2015-2020) (Million US$)
Table 25. Global Human Microbiome Modulators Market Share by Players (2015-2020)
Table 26. Global Top Human Microbiome Modulators Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Microbiome Modulators as of 2019)
Table 27. Global Human Microbiome Modulators by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Human Microbiome Modulators Product Solution and Service
Table 30. Date of Enter into Human Microbiome Modulators Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Human Microbiome Modulators Market Size by Type (2015-2020) (Million US$)
Table 33. Global Human Microbiome Modulators Market Size Share by Type (2015-2020)
Table 34. Global Human Microbiome Modulators Revenue Market Share by Type (2021-2026)
Table 35. Global Human Microbiome Modulators Market Size Share by Application (2015-2020)
Table 36. Global Human Microbiome Modulators Market Size by Application (2015-2020) (Million US$)
Table 37. Global Human Microbiome Modulators Market Size Share by Application (2021-2026)
Table 38. North America Key Players Human Microbiome Modulators Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Human Microbiome Modulators Market Share (2019-2020)
Table 40. North America Human Microbiome Modulators Market Size by Type (2015-2020) (Million US$)
Table 41. North America Human Microbiome Modulators Market Share by Type (2015-2020)
Table 42. North America Human Microbiome Modulators Market Size by Application (2015-2020) (Million US$)
Table 43. North America Human Microbiome Modulators Market Share by Application (2015-2020)
Table 44. Europe Key Players Human Microbiome Modulators Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Human Microbiome Modulators Market Share (2019-2020)
Table 46. Europe Human Microbiome Modulators Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Human Microbiome Modulators Market Share by Type (2015-2020)
Table 48. Europe Human Microbiome Modulators Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Human Microbiome Modulators Market Share by Application (2015-2020)
Table 50. China Key Players Human Microbiome Modulators Revenue (2019-2020) (Million US$)
Table 51. China Key Players Human Microbiome Modulators Market Share (2019-2020)
Table 52. China Human Microbiome Modulators Market Size by Type (2015-2020) (Million US$)
Table 53. China Human Microbiome Modulators Market Share by Type (2015-2020)
Table 54. China Human Microbiome Modulators Market Size by Application (2015-2020) (Million US$)
Table 55. China Human Microbiome Modulators Market Share by Application (2015-2020)
Table 56. Japan Key Players Human Microbiome Modulators Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Human Microbiome Modulators Market Share (2019-2020)
Table 58. Japan Human Microbiome Modulators Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Human Microbiome Modulators Market Share by Type (2015-2020)
Table 60. Japan Human Microbiome Modulators Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Human Microbiome Modulators Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Human Microbiome Modulators Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Human Microbiome Modulators Market Share (2019-2020)
Table 64. Southeast Asia Human Microbiome Modulators Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Human Microbiome Modulators Market Share by Type (2015-2020)
Table 66. Southeast Asia Human Microbiome Modulators Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Human Microbiome Modulators Market Share by Application (2015-2020)
Table 68. India Key Players Human Microbiome Modulators Revenue (2019-2020) (Million US$)
Table 69. India Key Players Human Microbiome Modulators Market Share (2019-2020)
Table 70. India Human Microbiome Modulators Market Size by Type (2015-2020) (Million US$)
Table 71. India Human Microbiome Modulators Market Share by Type (2015-2020)
Table 72. India Human Microbiome Modulators Market Size by Application (2015-2020) (Million US$)
Table 73. India Human Microbiome Modulators Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Human Microbiome Modulators Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Human Microbiome Modulators Market Share (2019-2020)
Table 76. Central & South America Human Microbiome Modulators Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Human Microbiome Modulators Market Share by Type (2015-2020)
Table 78. Central & South America Human Microbiome Modulators Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Human Microbiome Modulators Market Share by Application (2015-2020)
Table 80. Bayer Company Details
Table 81. Bayer Business Overview
Table 82. Bayer Product
Table 83. Bayer Revenue in Human Microbiome Modulators Business (2015-2020) (Million US$)
Table 84. Bayer Recent Development
Table 85. BioGaia Company Details
Table 86. BioGaia Business Overview
Table 87. BioGaia Product
Table 88. BioGaia Revenue in Human Microbiome Modulators Business (2015-2020) (Million US$)
Table 89. BioGaia Recent Development
Table 90. Chr. Hansen Holding Company Details
Table 91. Chr. Hansen Holding Business Overview
Table 92. Chr. Hansen Holding Product
Table 93. Chr. Hansen Holding Revenue in Human Microbiome Modulators Business (2015-2020) (Million US$)
Table 94. Chr. Hansen Holding Recent Development
Table 95. DowDuPont Company Details
Table 96. DowDuPont Business Overview
Table 97. DowDuPont Product
Table 98. DowDuPont Revenue in Human Microbiome Modulators Business (2015-2020) (Million US$)
Table 99. DowDuPont Recent Development
Table 100. Ingredion Company Details
Table 101. Ingredion Business Overview
Table 102. Ingredion Product
Table 103. Ingredion Revenue in Human Microbiome Modulators Business (2015-2020) (Million US$)
Table 104. Ingredion Recent Development
Table 105. ISOThrive Company Details
Table 106. ISOThrive Business Overview
Table 107. ISOThrive Product
Table 108. ISOThrive Revenue in Human Microbiome Modulators Business (2015-2020) (Million US$)
Table 109. ISOThrive Recent Development
Table 110. Jarrow Formulas Company Details
Table 111. Jarrow Formulas Business Overview
Table 112. Jarrow Formulas Product
Table 113. Jarrow Formulas Revenue in Human Microbiome Modulators Business (2015-2020) (Million US$)
Table 114. Jarrow Formulas Recent Development
Table 115. DSM Business Overview
Table 116. DSM Product
Table 117. DSM Company Details
Table 118. DSM Revenue in Human Microbiome Modulators Business (2015-2020) (Million US$)
Table 119. DSM Recent Development
Table 120. Lallemand Company Details
Table 121. Lallemand Business Overview
Table 122. Lallemand Product
Table 123. Lallemand Revenue in Human Microbiome Modulators Business (2015-2020) (Million US$)
Table 124. Lallemand Recent Development
Table 125. Sanofi Company Details
Table 126. Sanofi Business Overview
Table 127. Sanofi Product
Table 128. Sanofi Revenue in Human Microbiome Modulators Business (2015-2020) (Million US$)
Table 129. Sanofi Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
Table 1. Human Microbiome Modulators Key Market Segments
Table 2. Key Players Covered: Ranking by Human Microbiome Modulators Revenue
Table 3. Ranking of Global Top Human Microbiome Modulators Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Human Microbiome Modulators Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Probiotics and Creams
Table 6. Key Players of Prebiotics and Dietary Supplements
Table 7. Key Players of Drugs
Table 8. COVID-19 Impact Global Market: (Four Human Microbiome Modulators Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Human Microbiome Modulators Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Human Microbiome Modulators Players to Combat Covid-19 Impact
Table 13. Global Human Microbiome Modulators Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Human Microbiome Modulators Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Human Microbiome Modulators Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Human Microbiome Modulators Market Share by Regions (2015-2020)
Table 17. Global Human Microbiome Modulators Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Human Microbiome Modulators Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Human Microbiome Modulators Market Growth Strategy
Table 23. Main Points Interviewed from Key Human Microbiome Modulators Players
Table 24. Global Human Microbiome Modulators Revenue by Players (2015-2020) (Million US$)
Table 25. Global Human Microbiome Modulators Market Share by Players (2015-2020)
Table 26. Global Top Human Microbiome Modulators Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Microbiome Modulators as of 2019)
Table 27. Global Human Microbiome Modulators by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Human Microbiome Modulators Product Solution and Service
Table 30. Date of Enter into Human Microbiome Modulators Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Human Microbiome Modulators Market Size by Type (2015-2020) (Million US$)
Table 33. Global Human Microbiome Modulators Market Size Share by Type (2015-2020)
Table 34. Global Human Microbiome Modulators Revenue Market Share by Type (2021-2026)
Table 35. Global Human Microbiome Modulators Market Size Share by Application (2015-2020)
Table 36. Global Human Microbiome Modulators Market Size by Application (2015-2020) (Million US$)
Table 37. Global Human Microbiome Modulators Market Size Share by Application (2021-2026)
Table 38. North America Key Players Human Microbiome Modulators Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Human Microbiome Modulators Market Share (2019-2020)
Table 40. North America Human Microbiome Modulators Market Size by Type (2015-2020) (Million US$)
Table 41. North America Human Microbiome Modulators Market Share by Type (2015-2020)
Table 42. North America Human Microbiome Modulators Market Size by Application (2015-2020) (Million US$)
Table 43. North America Human Microbiome Modulators Market Share by Application (2015-2020)
Table 44. Europe Key Players Human Microbiome Modulators Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Human Microbiome Modulators Market Share (2019-2020)
Table 46. Europe Human Microbiome Modulators Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Human Microbiome Modulators Market Share by Type (2015-2020)
Table 48. Europe Human Microbiome Modulators Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Human Microbiome Modulators Market Share by Application (2015-2020)
Table 50. China Key Players Human Microbiome Modulators Revenue (2019-2020) (Million US$)
Table 51. China Key Players Human Microbiome Modulators Market Share (2019-2020)
Table 52. China Human Microbiome Modulators Market Size by Type (2015-2020) (Million US$)
Table 53. China Human Microbiome Modulators Market Share by Type (2015-2020)
Table 54. China Human Microbiome Modulators Market Size by Application (2015-2020) (Million US$)
Table 55. China Human Microbiome Modulators Market Share by Application (2015-2020)
Table 56. Japan Key Players Human Microbiome Modulators Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Human Microbiome Modulators Market Share (2019-2020)
Table 58. Japan Human Microbiome Modulators Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Human Microbiome Modulators Market Share by Type (2015-2020)
Table 60. Japan Human Microbiome Modulators Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Human Microbiome Modulators Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Human Microbiome Modulators Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Human Microbiome Modulators Market Share (2019-2020)
Table 64. Southeast Asia Human Microbiome Modulators Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Human Microbiome Modulators Market Share by Type (2015-2020)
Table 66. Southeast Asia Human Microbiome Modulators Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Human Microbiome Modulators Market Share by Application (2015-2020)
Table 68. India Key Players Human Microbiome Modulators Revenue (2019-2020) (Million US$)
Table 69. India Key Players Human Microbiome Modulators Market Share (2019-2020)
Table 70. India Human Microbiome Modulators Market Size by Type (2015-2020) (Million US$)
Table 71. India Human Microbiome Modulators Market Share by Type (2015-2020)
Table 72. India Human Microbiome Modulators Market Size by Application (2015-2020) (Million US$)
Table 73. India Human Microbiome Modulators Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Human Microbiome Modulators Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Human Microbiome Modulators Market Share (2019-2020)
Table 76. Central & South America Human Microbiome Modulators Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Human Microbiome Modulators Market Share by Type (2015-2020)
Table 78. Central & South America Human Microbiome Modulators Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Human Microbiome Modulators Market Share by Application (2015-2020)
Table 80. Bayer Company Details
Table 81. Bayer Business Overview
Table 82. Bayer Product
Table 83. Bayer Revenue in Human Microbiome Modulators Business (2015-2020) (Million US$)
Table 84. Bayer Recent Development
Table 85. BioGaia Company Details
Table 86. BioGaia Business Overview
Table 87. BioGaia Product
Table 88. BioGaia Revenue in Human Microbiome Modulators Business (2015-2020) (Million US$)
Table 89. BioGaia Recent Development
Table 90. Chr. Hansen Holding Company Details
Table 91. Chr. Hansen Holding Business Overview
Table 92. Chr. Hansen Holding Product
Table 93. Chr. Hansen Holding Revenue in Human Microbiome Modulators Business (2015-2020) (Million US$)
Table 94. Chr. Hansen Holding Recent Development
Table 95. DowDuPont Company Details
Table 96. DowDuPont Business Overview
Table 97. DowDuPont Product
Table 98. DowDuPont Revenue in Human Microbiome Modulators Business (2015-2020) (Million US$)
Table 99. DowDuPont Recent Development
Table 100. Ingredion Company Details
Table 101. Ingredion Business Overview
Table 102. Ingredion Product
Table 103. Ingredion Revenue in Human Microbiome Modulators Business (2015-2020) (Million US$)
Table 104. Ingredion Recent Development
Table 105. ISOThrive Company Details
Table 106. ISOThrive Business Overview
Table 107. ISOThrive Product
Table 108. ISOThrive Revenue in Human Microbiome Modulators Business (2015-2020) (Million US$)
Table 109. ISOThrive Recent Development
Table 110. Jarrow Formulas Company Details
Table 111. Jarrow Formulas Business Overview
Table 112. Jarrow Formulas Product
Table 113. Jarrow Formulas Revenue in Human Microbiome Modulators Business (2015-2020) (Million US$)
Table 114. Jarrow Formulas Recent Development
Table 115. DSM Business Overview
Table 116. DSM Product
Table 117. DSM Company Details
Table 118. DSM Revenue in Human Microbiome Modulators Business (2015-2020) (Million US$)
Table 119. DSM Recent Development
Table 120. Lallemand Company Details
Table 121. Lallemand Business Overview
Table 122. Lallemand Product
Table 123. Lallemand Revenue in Human Microbiome Modulators Business (2015-2020) (Million US$)
Table 124. Lallemand Recent Development
Table 125. Sanofi Company Details
Table 126. Sanofi Business Overview
Table 127. Sanofi Product
Table 128. Sanofi Revenue in Human Microbiome Modulators Business (2015-2020) (Million US$)
Table 129. Sanofi Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Human Microbiome Modulators Market Share by Type: 2020 VS 2026
Figure 2. Probiotics and Creams Features
Figure 3. Prebiotics and Dietary Supplements Features
Figure 4. Drugs Features
Figure 5. Global Human Microbiome Modulators Market Share by Application: 2020 VS 2026
Figure 6. Digestive Health Case Studies
Figure 7. Immune Health Case Studies
Figure 8. Oral Health Case Studies
Figure 9. Others Case Studies
Figure 10. Human Microbiome Modulators Report Years Considered
Figure 11. Global Human Microbiome Modulators Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Human Microbiome Modulators Market Share by Regions: 2020 VS 2026
Figure 13. Global Human Microbiome Modulators Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Human Microbiome Modulators Market Share by Players in 2019
Figure 16. Global Top Human Microbiome Modulators Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Microbiome Modulators as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Human Microbiome Modulators Revenue in 2019
Figure 18. North America Human Microbiome Modulators Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Human Microbiome Modulators Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Human Microbiome Modulators Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Human Microbiome Modulators Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Human Microbiome Modulators Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Human Microbiome Modulators Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Human Microbiome Modulators Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Bayer Revenue Growth Rate in Human Microbiome Modulators Business (2015-2020)
Figure 27. BioGaia Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. BioGaia Revenue Growth Rate in Human Microbiome Modulators Business (2015-2020)
Figure 29. Chr. Hansen Holding Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Chr. Hansen Holding Revenue Growth Rate in Human Microbiome Modulators Business (2015-2020)
Figure 31. DowDuPont Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. DowDuPont Revenue Growth Rate in Human Microbiome Modulators Business (2015-2020)
Figure 33. Ingredion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Ingredion Revenue Growth Rate in Human Microbiome Modulators Business (2015-2020)
Figure 35. ISOThrive Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. ISOThrive Revenue Growth Rate in Human Microbiome Modulators Business (2015-2020)
Figure 37. Jarrow Formulas Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Jarrow Formulas Revenue Growth Rate in Human Microbiome Modulators Business (2015-2020)
Figure 39. DSM Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. DSM Revenue Growth Rate in Human Microbiome Modulators Business (2015-2020)
Figure 41. Lallemand Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Lallemand Revenue Growth Rate in Human Microbiome Modulators Business (2015-2020)
Figure 43. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Sanofi Revenue Growth Rate in Human Microbiome Modulators Business (2015-2020)
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed
Figure 1. Global Human Microbiome Modulators Market Share by Type: 2020 VS 2026
Figure 2. Probiotics and Creams Features
Figure 3. Prebiotics and Dietary Supplements Features
Figure 4. Drugs Features
Figure 5. Global Human Microbiome Modulators Market Share by Application: 2020 VS 2026
Figure 6. Digestive Health Case Studies
Figure 7. Immune Health Case Studies
Figure 8. Oral Health Case Studies
Figure 9. Others Case Studies
Figure 10. Human Microbiome Modulators Report Years Considered
Figure 11. Global Human Microbiome Modulators Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Human Microbiome Modulators Market Share by Regions: 2020 VS 2026
Figure 13. Global Human Microbiome Modulators Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Human Microbiome Modulators Market Share by Players in 2019
Figure 16. Global Top Human Microbiome Modulators Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Microbiome Modulators as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Human Microbiome Modulators Revenue in 2019
Figure 18. North America Human Microbiome Modulators Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Human Microbiome Modulators Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Human Microbiome Modulators Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Human Microbiome Modulators Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Human Microbiome Modulators Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Human Microbiome Modulators Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Human Microbiome Modulators Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Bayer Revenue Growth Rate in Human Microbiome Modulators Business (2015-2020)
Figure 27. BioGaia Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. BioGaia Revenue Growth Rate in Human Microbiome Modulators Business (2015-2020)
Figure 29. Chr. Hansen Holding Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Chr. Hansen Holding Revenue Growth Rate in Human Microbiome Modulators Business (2015-2020)
Figure 31. DowDuPont Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. DowDuPont Revenue Growth Rate in Human Microbiome Modulators Business (2015-2020)
Figure 33. Ingredion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Ingredion Revenue Growth Rate in Human Microbiome Modulators Business (2015-2020)
Figure 35. ISOThrive Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. ISOThrive Revenue Growth Rate in Human Microbiome Modulators Business (2015-2020)
Figure 37. Jarrow Formulas Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Jarrow Formulas Revenue Growth Rate in Human Microbiome Modulators Business (2015-2020)
Figure 39. DSM Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. DSM Revenue Growth Rate in Human Microbiome Modulators Business (2015-2020)
Figure 41. Lallemand Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Lallemand Revenue Growth Rate in Human Microbiome Modulators Business (2015-2020)
Figure 43. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Sanofi Revenue Growth Rate in Human Microbiome Modulators Business (2015-2020)
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed
